Skip to content

Omeros OMER Interest On Contract Royalty Asset

Interest On Contract Royalty Asset at other companies

XOMA Corporation logo
XOMA CorporationXOMA
$9.24M+52.2%
PVL
Palvella TherapeuticsPVLA
-$2.04M-67.8%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
-$4.8M-1,140%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$325K+0.9%
Rumble, Inc. logo
Rumble, Inc.RUM
$1.89M-13.7%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$55.17M-4.6%

Other financials

Income statement

See full
Revenue$9.9M
Gross profit$29.7M
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$775.86M+313%
P/S8.6×

Profitability

See full
Gross margin98.9%
Operating margin-181.8%
Net margin-136.6%
FCF margin-121.6%

Returns & leverage

See full
Return on equity86.6%
Debt / equity0.3×-1.1×
Current ratio+1.9×

Where this comes from

Reported directly by Omeros in its filing.

Tagged under the XBRL concept omer:InterestOnContractRoyaltyAsset.

The official record: Omeros’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omeros's interest on contract royalty asset.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omeros's interest on contract royalty asset?
Omeros (OMER) reported interest on contract royalty asset of $3.13M in Q1 2026.
How has Omeros's interest on contract royalty asset changed year-over-year?
Omeros's interest on contract royalty asset decreased by 20.8% year-over-year, from $3.95M to $3.13M.
What does interest on contract royalty asset mean?
Represents the interest income or accretion recognized on assets derived from contractual royalty rights. It reflects the time-value component of expected future royalty streams recognized under accounting standards. This metric helps investors assess the yield and valuation trajectory of the company's intangible royalty assets.